-
Product Insights
Uveitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Uveitis - Drugs In Development, 2023’, provides an overview of the Uveitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Uveitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Glaucoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Glaucoma - Drugs In Development, 2023’, provides an overview of the Glaucoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Glaucoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Retinitis Pigmentosa (Retinitis) – Drugs In Development, 2023
Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Drugs In Development, 2023’, provides an overview of the Retinitis Pigmentosa (Retinitis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Retinitis Pigmentosa (Retinitis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Macular Edema – Drugs In Development, 2023
Global Markets Direct’s, ‘Macular Edema - Drugs In Development, 2023’, provides an overview of the Macular Edema pipeline landscape. The report provides comprehensive information on the therapeutics under development for Macular Edema, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Company Insights
Credit Agricole S.A. – Digital Transformation Strategies
Credit Agricole Digital Transformation Strategies Overview Credit Agricole is leveraging emerging technologies as a part of its digital transformation strategies. The annual ICT spending of Credit Agricole was estimated at $1.6 billion in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and network and communications from vendors. Credit Agricole SA (Credit Agricole), a subsidiary of SAS Rue La Boetie, is a provider of banking and related financial services. Its portfolio of offerings is classified...
-
Sector Analysis
Green Bites – Key Disruptive Forces in Sustainable Nutrition
Disruptive Forces in Sustainable Nutrition Report Overview Advanced developments such as edible insects, food 3D printing, and plant-based proteins are redefining food efficiency and environmental impact in the sustainable nutrition domain. Innovation Curve: Consumer Buy the Full Report to Know More about the Disruptive Forces in Sustainable Nutrition Download a Free Report Sample The ‘Green Bites – Key Disruptive Forces in Sustainable Nutrition’ FutureTech series report categorizes the key innovation areas in sustainable nutrition as emerging, accelerating, and maturing. The...
-
Company Insights
American Express (Amex) – Digital Transformation Strategies
American Express Digital Transformation Strategies Report Overview American Express is leveraging emerging technologies as a part of its digital transformation strategies. The annual ICT spending of American Express was estimated at $2.4 billion in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. American Express (Amex) is a provider of card products and travel-related services. It offers a range of credit cards, charge cards, and other payment and financing solutions to...
-
Company Insights
Skandinaviska Enskilda Banken (SEB) – Digital Transformation Strategies
SEB Digital Transformation Strategies Report Overview Skandinaviska Enskilda Banken (SEB) has been focusing on using artificial intelligence, open banking, machine learning, and data analytics to digitally transform its operations. The annual ICT spending of SEB was estimated at $365.4 million for 2023. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. SEB provides corporate and institutional banking as well as retail and SME banking. Corporate and institutional banking offers life insurance, pensions,...
-
Product Insights
Derrill Water Solar PV Park
Derrill Water Solar PV Park is a solar PV project located in England, United Kingdom. The project is owned by Ripple Energy Ltd and is developed by Renewable Energy Systems Ltd. The project is at the permitting stage. Empower your strategies with our Derrill Water Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...